SEC Form 4 · accession 0001209191-15-029013
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas J. Schall
Officer — President and CEO · Director
Period of report
Mar 20, 2015
Accepted (ET)
Mar 24, 2015 · 7:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 20, 2015 | M | 14,315 | $0.60 | A | 2,162,982 | D | |
| Common StockF2,F3 | Mar 20, 2015 | S | 14,315 | $7.9957 | D | 2,148,667 | D | |
| Common Stock | Mar 23, 2015 | M | 19,291 | $0.60 | A | 2,167,958 | D | |
| Common StockF2,F4 | Mar 23, 2015 | S | 19,291 | $7.7683 | D | 2,148,667 | D | |
| Common Stock | Mar 24, 2015 | M | 16,765 | $0.60 | A | 2,165,432 | D | |
| Common StockF2,F5 | Mar 24, 2015 | S | 16,765 | $7.8043 | D | 2,148,667 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F6 | $0.60 | Mar 20, 2015 | M | 14,315 | D | May 5, 2005 | May 5, 2015 | Common Stock | 14,315 | 61,223 | D |
| Stock Option (right to buy)F6 | $0.60 | Mar 23, 2015 | M | 19,291 | D | May 5, 2005 | May 5, 2015 | Common Stock | 19,291 | 41,932 | D |
| Stock Option (right to buy)F6 | $0.60 | Mar 24, 2015 | M | 16,765 | D | May 5, 2005 | May 5, 2015 | Common Stock | 16,765 | 25,167 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2Shares sold are associated with stock options which will expire in May 2015.
- F3Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.76 to $8.32 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- F4Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.50 to $7.95 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- F5Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.62 to $7.99 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- F6As of March 20, 2015 and prior to this transaction, the option fully vested.